NCT07488507 is a NA clinical trial of EBUS-TBMCB in Mediastinal Metastases of Lung Cancer, sponsored by Third Military Medical University.

Who is sponsoring NCT07488507?

NCT07488507 is sponsored by Third Military Medical University.

What drugs are being tested in NCT07488507?

Interventions in NCT07488507: EBUS-TBMCB.

What condition does NCT07488507 study?

NCT07488507 studies Mediastinal Metastases of Lung Cancer.

Is NCT07488507 still recruiting?

NCT07488507 is currently recruiting now. Last updated 23 March 2026.

Last reviewed 2026-03-23 · How we verify

NCT07488507

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Value and Safety of Combined Biopsy for Mediastinal Metastasis of Lung Cancer

Recruiting now NA Last updated 23 March 2026

What this trial tests

NA trial testing EBUS-TBMCB in Mediastinal Metastases of Lung Cancer in 240 participants. Currently enrolling.

Timeline

20 March 2026

Primary endpoint
1 March 2030

1 March 2030

Quick facts

Lead sponsor	Third Military Medical University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	diagnostic
Enrollment	240
Start date	20 March 2026
Primary completion	1 March 2030
Estimated completion	1 March 2030
Sites	1 location across China

Drugs / interventions tested

EBUS-TBMCB

Conditions studied

Mediastinal Metastases of Lung Cancer — all drugs for Mediastinal Metastases of Lung Cancer →

Sponsor

Third Military Medical University

Who can join

18 and older, any sex, with Mediastinal Metastases of Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is aimed o evaluate the diagnostic performance and treatment guidance of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) combined with transbronchial mediastinal cryobiopsy (EBUS-TBMCB) in patients with mediastinal metastases of lung cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of EBUS-TBMCB

Trials testing the same drug.

NCT04572984 — Transbronchial Mediastinal Cryobiopsy Combined With EBUS-TBNA in the Diagnosis of Mediastinal Lesions · NA · completed

Other Third Military Medical University trials

Trials by the same sponsor.

NCT07536477 — High-flow Nasal Cannula Oxygen Therapy Versus Conventional Oxygen Therapy in High-altitude Pulmonary Edema · NA · not yet recruiting
NCT07277907 — Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit Constipation · Phase 3 · recruiting
NCT04557995 — Erythrocytapheresis for Chronic Mountain Sickness · NA · recruiting
NCT07036588 — PARLAR-02 Trial：Modified Transanal Drainage Tube Use for Preventing Anastomotic Leakage · NA · recruiting
NCT07051694 — Transcutaneous Auricular Vagus Nerve Stimulation as Adjuvant Treatment for Sepsis Patients · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07488507 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Third Military Medical University
Last refreshed: 23 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07488507.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing